clinical
trials

about glioma | clinical trials | additional resources

 

In addition to existing treatments for brain tumors, there are several promising new treatments and procedures currently being studied in clinical trials. If you or a family member has been diagnosed with a brain tumor or some other form of cancer, discuss with your treating physician whether entering a clinical trial might be a good option.

TransMolecular, Inc. is active studies patients with high-grade malignant glioma (anaplastic astrocytoma and glioblastoma multiforme), metastatic brain tumors, and/or metastatic tumors in other areas of the body.

For more information, prospective patients or their physicians should contact Amy Bock, TransMolecular's Senior Director, Clinical Operations at 617-995-3050 x 316 or by email at bock@transmolecular.com

 

More information about TransMolecular clinical trials active studies patients can also be found at the following websites:

Clinical trials.gov
TM601-002 (Glioma phase II)
TM601-003 (imaging study, solid tumors – brain, lung, et al)

National Cancer Institute
TM601-002

Emerging Medicine
TM601-002 (Glioma phase II)
TM601-003 (imaging study, solid tumors - brain, lung, et al)

Virtual Trials
TM601-002 (Glioma phase II)
TM601-003 (imaging study, solid tumors – brain, lung, et al)

 

 
company overview | management | board of directors | investors | medical advisory board | product pipeline | publications & abstracts | completed glioma clinical trials | active studies | media relations | press releases | abstracts & articles | in the news | events | research & development | additional resources | advancing targeted cancer therapy | clinical trials | disease information | news | about glioma | glioma | other primary brain tumors | metastatic brain tumors | contact us | careers | site map